September 12th 2024
The trial showcased the continued efficacy of apremilast, with 2-year data on the forefront.
Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis
November 21, 2024 - December 5, 2024
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Indoor tanning restrictions top priority for AAD
November 1st 2006On behalf of the American Academy of Dermatology, I would like to respond to a letter to the editor from Michael Franzblau, M.D., regarding the Academy's efforts to restrict access to indoor tanning equipment. ("Cannot fathom AAD/AADA indifference toward indoor tanning regs," September, 2006). The letter's criticisms are not supported by the facts, and I appreciate the opportunity to set the record straight.
How best to communicate with ...
November 1st 2006"Usually, when kids go to the clinic, especially if they're little, they get so many vaccinations that when one takes off their clothes, they think they're getting a shot," explains Papri Sarkar, M.D., a third-year resident in Harvard's dermatology training program. "Also, I try to avoid using gloves unless they're clinically necessary."
Childhood cutaneous T-cell lymphomas on rise, experts say
November 1st 2006National report - The two forms of cutaneous T-cell lymphomas (CTCL), mycosis fungoides (MF) and S?zary syndrome, are reported to arise more often in adults than in children. But the incidence of cutaneous T-cell lymphomas appears to be on the rise in children and adolescents.
British study finds Roaccutane treatment causes depression-like symptoms in mice
October 3rd 2006Bath, England - In the wake of claims that severe-acne treatment Roaccutane has caused depression and suicide in patients since its introduction in 1982, researchers at the University of Bath have tested the medication and found the claims may have merit.